Sector Update: Health Care Stocks Advance Wednesday Afternoon

MT Newswires Live08-28

Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.

The iShares Biotechnology ETF (IBB) was little changed.

In corporate news, the scope of the US Department of Justice's investigation into UnitedHealth (UNH) goes beyond previously disclosed allegations of Medicare fraud with the DOJ also looking into the insurer's prescription management services and how it reimburses its doctors, Bloomberg reported. UnitedHealth shares rose 1.2%.

Pfizer (PFE) and BioNTech (BNTX) said the US Food and Drug Administration approved a supplemental license application for their LP.8.1-adapted monovalent COVID-19 vaccine for use in adults ages 65 and older and people ages 5 through 64 with at least one underlying condition that leaves them at high risk of severe outcomes from COVID-19. Pfizer shares rose 0.4%, and BioNTech fell 2.3%.

Eli Lilly (LLY) said that its drug Verzenio, when combined with endocrine therapy in a late-stage study, showed a statistically significant improvement in overall survival in patients with a certain type of breast cancer, compared to endocrine therapy alone. Eli Lilly shares added 0.1%.

Azitra (AZTR) shares surged 29% after the company dosed the first patient in a phase 1/2 trial assessing its ATR04-484 biotherapeutic candidate intended to treat skin rashes associated with epidermal growth factor receptor inhibitors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2562721817?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-28 01:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562721817","market":"hk","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Advance Wednesday Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was little changed.</p><p>In corporate news, the scope of the US Department of Justice's investigation into UnitedHealth (UNH) goes beyond previously disclosed allegations of Medicare fraud with the DOJ also looking into the insurer's prescription management services and how it reimburses its doctors, Bloomberg reported. UnitedHealth shares rose 1.2%.</p><p>Pfizer (PFE) and BioNTech (BNTX) said the US Food and Drug Administration approved a supplemental license application for their LP.8.1-adapted monovalent COVID-19 vaccine for use in adults ages 65 and older and people ages 5 through 64 with at least one underlying condition that leaves them at high risk of severe outcomes from COVID-19. Pfizer shares rose 0.4%, and BioNTech fell 2.3%.</p><p>Eli Lilly (LLY) said that its drug Verzenio, when combined with endocrine therapy in a late-stage study, showed a statistically significant improvement in overall survival in patients with a certain type of breast cancer, compared to endocrine therapy alone. Eli Lilly shares added 0.1%.</p><p>Azitra (AZTR) shares surged 29% after the company dosed the first patient in a phase 1/2 trial assessing its ATR04-484 biotherapeutic candidate intended to treat skin rashes associated with epidermal growth factor receptor inhibitors.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Advance Wednesday Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Advance Wednesday Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-28 01:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was little changed.</p><p>In corporate news, the scope of the US Department of Justice's investigation into UnitedHealth (UNH) goes beyond previously disclosed allegations of Medicare fraud with the DOJ also looking into the insurer's prescription management services and how it reimburses its doctors, Bloomberg reported. UnitedHealth shares rose 1.2%.</p><p>Pfizer (PFE) and BioNTech (BNTX) said the US Food and Drug Administration approved a supplemental license application for their LP.8.1-adapted monovalent COVID-19 vaccine for use in adults ages 65 and older and people ages 5 through 64 with at least one underlying condition that leaves them at high risk of severe outcomes from COVID-19. Pfizer shares rose 0.4%, and BioNTech fell 2.3%.</p><p>Eli Lilly (LLY) said that its drug Verzenio, when combined with endocrine therapy in a late-stage study, showed a statistically significant improvement in overall survival in patients with a certain type of breast cancer, compared to endocrine therapy alone. Eli Lilly shares added 0.1%.</p><p>Azitra (AZTR) shares surged 29% after the company dosed the first patient in a phase 1/2 trial assessing its ATR04-484 biotherapeutic candidate intended to treat skin rashes associated with epidermal growth factor receptor inhibitors.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B19Z8W00.USD","symbol_name":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2562721817","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562721817","pubTimestamp":1756317546,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.The iShares Biotechnology ETF (IBB) was little changed","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","BK4599":"减肥药","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU0882574055.USD":"富达全球健康医疗A ACC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BNTX":"BioNTech SE","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","BK4535":"淡马锡持仓","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","UNH":"联合健康","PFE":"辉瑞","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","IBB":"生物科技指数ETF-iShares Nasdaq","BK4007":"制药","AZTR":"Azitra Inc","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","XLV":"健康照护类股ETF-SPDR","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","PFE.AU":"PANTERA MINERALS LTD","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD"},"translate_title":"行业更新：医疗保健股周三下午上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE.AU":1,"PFE":0.9,"XLV":1,"AZTR":0.9,"UNH":0.9,"BNTX":0.9,"IBB":1},"content_text":"Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.The iShares Biotechnology ETF (IBB) was little changed.In corporate news, the scope of the US Department of Justice's investigation into UnitedHealth (UNH) goes beyond previously disclosed allegations of Medicare fraud with the DOJ also looking into the insurer's prescription management services and how it reimburses its doctors, Bloomberg reported. UnitedHealth shares rose 1.2%.Pfizer (PFE) and BioNTech (BNTX) said the US Food and Drug Administration approved a supplemental license application for their LP.8.1-adapted monovalent COVID-19 vaccine for use in adults ages 65 and older and people ages 5 through 64 with at least one underlying condition that leaves them at high risk of severe outcomes from COVID-19. Pfizer shares rose 0.4%, and BioNTech fell 2.3%.Eli Lilly (LLY) said that its drug Verzenio, when combined with endocrine therapy in a late-stage study, showed a statistically significant improvement in overall survival in patients with a certain type of breast cancer, compared to endocrine therapy alone. Eli Lilly shares added 0.1%.Azitra (AZTR) shares surged 29% after the company dosed the first patient in a phase 1/2 trial assessing its ATR04-484 biotherapeutic candidate intended to treat skin rashes associated with epidermal growth factor receptor inhibitors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2562721817","isCrawlerRequest":true}